Industrial, Manufacturing & Heavy Industry Market News

Alopecia drugs market to grow at 5.02% CAGR to 2020 according to new industry research report

Global Alopecia Drugs Market 2016-2020, report covers the present scenario and the growth prospects of the global alopecia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of alopecia drugs.

Global Alopecia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market.

Report: www.reportsnreports.com/contacts/759419

This analyst forecast the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.

- Advertising -

- Agency -

Alopecia is a loss of hair and can occur at any age across the genders.

The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. Few of the primary ones are a sedentary lifestyle, unhealthy diets, and side effects of certain medical treatments.

Moreover, hormonal imbalance and aging increase the probability of developing a chronic disease like cancer, arthritis, depression, and hypertension, which would also lead to hair loss, especially among middle-to-late-aged people.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Access this Report at www.reportsnreports.com/759419

Key vendors

  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck

Other prominent vendors

  • Aclaris Therapeutics
  • Actelion Pharmaceuticals
  • Almirall
  • AndroScience
  • Anterios
  • Aqua Pharmaceuticals
  • Astellas Pharma
  • Bayer HealthCare
  • BERG Health
  • BiologicsMD
  • BioPharmX
  • Celtaxsys
  • Cipher Pharmaceuticals
  • Concert Pharmaceuticals
  • Cosmo Pharmaceuticals
  • Dermira
  • Elorac
  • F. Hoffmann-La Roche
  • Foamix
  • Guthy-Renker
  • Helix BioMedix
  • Hygeia Therapeutics
  • Hyundai Pharm
  • Incyte
  • Kasiak Research
  • Kythera Biopharmaceuticals
  • Mylan
  • NovaLead Pharma
  • Novan
  • Oculus Innovative Sciences
  • Paratek Pharmaceuticals
  • Photocure
  • Polichem
  • Promius Pharma
  • Ranbaxy Laboratories
  • Reckitt Benckiser
  • Regience
  • Samumed
  • RepliCel
  • Skinvisible Pharmaceuticals
  • Teva Pharmaceutical
  • Versapharm
  • XBiotech

Market driver

  • Popularity of off-label and OTC drugs

Market challenge

  • Limited availability of approved drugs

Market trend

  • Emergence of laser technology and platelet-rich plasma (PRP) therapy

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
...